![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Sofosbuvir and Ribavirin Therapy for the Treatment of HIV/HCV Coinfected Patients With HCV GT 1-4 Infection: The PHOTON-1 and -2 Trials
|
|
|
Reported by Jules Levin
AASLD 2014 Nov 7-11 Boston
Jürgen K. Rockstroh1, Massimo Puoti2, Maribel Rodriguez-Torres3, Douglas.T Dieterich 4, Anuj Gaggar5, Liyun Ni5, Benedetta Massetto5, Evgenia Svarovskaia5, Diana Brainard5, G. Mani Subramanian5, John G. McHutchison5, Susanna Naggie6, Chloe Orkin7, Jean-Michel Molina8, Mark Sulkowski9
1University Hospital of Bonn, Germany; 2AO Ospedale Niguarda Ca' Granda, Milano, Italy; 3Fundacion De Investigacion, SJB School of Medicine, San Juan, Puerto Rico; 4Mount Sinai School of Medicine, New York, NY; 5Gilead Sciences, Inc., Foster City, CA; 6Duke Clinical Research Institute, Durham, NC; 7Barts Health NHS Trust, London, UK; 8University of Paris Diderot, Paris and Department of Infectious Diseases, Saint-Louis Hospital, Paris; 9Johns Hopkins University, Baltimore, MD
![AASLD1.gif](../images/111214/111214-8/AASLD1.gif)
![AASLD2.gif](../images/111214/111214-8/AASLD2.gif)
![AASLD3.gif](../images/111214/111214-8/AASLD3.gif)
![AASLD4.gif](../images/111214/111214-8/AASLD4.gif)
![AASLD5.gif](../images/111214/111214-8/AASLD5.gif)
![AASLD6.gif](../images/111214/111214-8/AASLD6.gif)
![AASLD7.gif](../images/111214/111214-8/AASLD7.gif)
![AASLD8.gif](../images/111214/111214-8/AASLD8.gif)
![AASLD9.gif](../images/111214/111214-8/AASLD9.gif)
![AASLD10.gif](../images/111214/111214-8/AASLD10.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|